Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
4,158.00
+2.80 (0.07%)
Apr 13, 2026, 3:29 PM IST
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 33.03B INR in the quarter ending December 31, 2025, with 17.59% growth. This brings the company's revenue in the last twelve months to 127.42B, up 12.74% year-over-year. In the fiscal year ending March 31, 2025, Torrent Pharmaceuticals had annual revenue of 115.16B with 7.35% growth.
Revenue (ttm)
127.42B
Revenue Growth
+12.74%
P/S Ratio
11.04
Revenue / Employee
7.47M
Employees
17,059
Market Cap
1.41T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 115.16B | 7.88B | 7.35% |
| Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
| Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
| Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
| Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Aurobindo Pharma | 331.82B |
| Cipla | 279.67B |
| Zydus Lifesciences | 260.89B |
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Mankind Pharma | 139.14B |
| Divi's Laboratories | 103.14B |
Torrent Pharmaceuticals News
- 3 days ago - Torrent Pharmaceuticals achieves zero observations in USFDA inspection - Business Upturn
- 13 days ago - Torrent Pharmaceuticals sells equity shares of UNM Foundation for Rs 5 lakh - Business Upturn
- 18 days ago - Torrent Pharmaceuticals receives corrigendum order from NCLT for J.B. Chemicals merger - Business Upturn
- 20 days ago - Torrent Pharmaceuticals receives NCLT approval for amalgamation with J.B. Chemicals - Business Upturn
- 23 days ago - Torrent Pharma launches India's first generic oral semaglutide - Business Upturn
- 26 days ago - Zydus and Torrent Pharma partner to co-market Semaglutide Injection in India - Business Upturn
- 6 weeks ago - Why Are Shares Of Xeris Biopharma Falling Friday? - Benzinga
- 7 weeks ago - Macquarie initiates coverage on Torrent Pharma with outperform, sets target price for stock at Rs 5,000 - Business Upturn